A retrospective, multicenter study evaluating Vcd versus Vrd based regimens as induction therapies in newly diagnosed patients with multiple myeloma
Latest Information Update: 04 Aug 2021
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 04 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association